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Abstract
Introduction Small intravascular volume, pathophysiological
hemorheology, and/or low cardiac output [CO] are assumed to
reduce available blood flow rates via common dual-lumen
catheters (except for those with a right atrium catheter tip
position) in the critically ill patient. We performed an
experimental animal study to verify these assumptions.
Methods Anesthetized, ventilated pigs (35 to 50 kg) were
allocated to different hemorheological conditions based on the
application of different volume substitutes (that is, colloids and
crystalloids, n = 6 to 7 per volume substitute). In a second step,
allocation to the final study group was performed after the
determination of the highest values for access flow (Qa) via an
axial dual-lumen catheter (11 French, 20 cm long, side holes)
placed in the femoral vein. High Qa rates (>300 ml/minute) were
allocated to the dual-lumen catheter group; low Qa rates were
switched to a 'dual-vein approach' using an alternative catheter
(8.5-French sheath) for separate blood delivery. Hemodynamics
(CO and central venous pressure [CVP]) and blood
composition (blood cell counts, plasma proteins, and colloid
osmotic pressure) were measured. Catheter tip positions and
vessel diameters were exemplified by computed tomography.
Results Forty-four percent of the animals required an alternative
vascular access due to only minimal Qa via the dual-lumen
catheter. Neither hemorheologically relevant aspects nor CO
and CVP correlated with the Qa achievable via the femoral vein
access. Even though the catheter tip of the alternative catheter
provided common iliac vein but not caval vein access, this
catheter type enabled higher Qa than the dual-lumen catheter
positioned in the caval vein.
Conclusion With respect to the femoral vein approach, none of
the commonly assumed reasons for limited Qa via the arterial
line of an axial dual-lumen catheter could be confirmed. The 8.5-
French sheath, though not engineered for that purpose,
performed quite well as an alternative catheter. Thus, in patients
lacking right jugular vein access with tip positioning of large-
French dual-lumen catheters in the right atrium, it would be of
interest to obtain clinical data re-evaluating the 'dual-vein
approach' with separate blood delivery via a tip-hole catheter in
order to provide high-volume hemofiltration.Page 1 of 11
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ACT = activated clotting time; ALB = albumin; Alt Cath = alternative catheter; BS = 'native' baseline; BW = body weight; CO = cardiac output; COP 
= colloid osmotic pressure; CT = computed tomography; CVP = central venous pressure; CVVH = continuous venovenous hemofiltration; fHb = free 
hemoglobin; Fib = fibrinogen; Hct = hematocrit; PQa = pressure of access flow; Pv = venous pressure; Qa = access flow; Qb = blood flow; TMP = 
transmembrane pressure; TP = total protein; WBC = white blood cell.
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Dual-lumen catheters, genuinely engineered for vascular
access in dialysis patients, are used for continuous veno-
venous hemofiltration (CVVH) in critically ill patients without
affecting potentially different requirements such as for throm-
bogenecity, flow resistance, or hemodynamics. Baldwin and
colleagues [1] described a mismatch of real blood flow (blood
flow [Qb]) achieved via the arterial line of dual-lumen catheters
and the Qb assumed to be achieved by the blood pumps. They
found that the length of the filter life was negatively correlated
with the percentage of Qb reduction by the pumps. Usually, in
patients in whom the achievable Qb rates for renal replace-
ment therapies are low, hemodynamics and hemorheology are
severely deteriorated. Both aspects are assumed to affect the
magnitude of negative pressure values arising from flow resist-
ance via the catheter and in turn for the access flow (Qa) avail-
able during CVVH. The right jugular vein approach, including
the catheter tip positioning in the right atrium [2], needs radio-
logical control and very strict policies with respect to thrombo-
genecity and infections [3] but provides a Qa of 300 to 400
ml/minute. For various reasons, the right internal jugular vein
approach is not feasible in all patients [4] and low Qb rates
may become the main reason for short filter running times and
limited clearance in crossflow-based apheresis filters [1,5-9].
Therefore, we performed a systematic experimental study in
anesthetized, ventilated pigs to assess the commonly
assumed correlation between the achievable Qb (achievable
Qa) via the arterial line of a dual-lumen catheter placed in the
femoral vein and the underlying hemodynamics (that is, car-
diac output [CO] and central venous pressure [CVP]), cathe-
ter tip position, and hemorheological features (blood
composition and volume substitute).
Materials and methods
Study design
The study design, including the assignment of animals to a
respective group, is explained in Figure 1a. In one group, an
axial dual-lumen catheter (GamCath®, a polyurethane, 11-
French, 20-cm-long, radiopaque catheter with blood return via
a tip and three side holes in longitudinal line and blood delivery
via five opposite side holes, as shown in Figure 1b; Gambro
Dialysatoren GmbH, Hechingen, Germany) was used to oper-
ate CVVH. In case of low-flow problems, an alternative cathe-
ter (Alt Cath) (venous, single-lumen, polyurethane, 8.5-French
sheath, 10-cm-long, radiopaque catheter chosen based on
explorative in vitro evaluation; Arrow Deutschland GmbH, Erd-
ing, Germany) was used. Immature pigs were used to provide
a wide range of different hemorheology patterns, CO values,
and blood vessel diameters, as found in intensive care patients
[6,8,9]. Furthermore, differences in volume management were
investigated by using the most common solutions, which
because of their rheological and anticoagulatory impact have
been discussed for years. A total of 34 pigs were randomly
assigned to fluid therapy with normal saline, 6% hydroxyethyl
starch at 130 kDa/0.4 degrees of substitution, 6% hydroxye-
thyl starch at 200 kDa/0.05 degrees of substitution (all from
Fresenius Kabi AG, Bad Homburg, Germany), albumin (ALB)
(human albumin 20% diluted to 4% with normal saline; Baxter
Deutschland GmbH, München-Unterschleißheim, Germany),
or gelatin polysuccinat (Gelafundin®; B. Braun Melsungen
AG, Melsungen, Germany). Ranges in CO, blood vessel diam-
eters, and basic blood/plasma composition were achieved
based on equally distributed differences of body weight (BW)
from 35 to 50 kg.
Identification of animals showing low flow rates via the 
dual-lumen catheter
All animals were placed in the supine position. After instrumen-
tation of the animals, measurements of all hemodynamic and
blood/plasma parameters for 'native' baseline (BS) were per-
formed to ensure comparable basic conditions for the experi-
ment. After bolus infusion of the respective volume substitute,
the CVVH was started (running seven hours in total) using
both lines of the inserted dual-lumen catheter, arterial and
venous. The highest Qb rates achievable were determined for
each animal, and accordingly they were allocated to one of the
catheter groups, dual-lumen (group 1) versus Alt Cath (group
2) (Figure 1a). Because we had to consider potential hemoly-
sis during high Qb rates within the hemofilter, we chose three
thresholds that limited increases in Qb: (a) catheter type-
related negative pressure arising from blood delivery via the
arterial line of the respective vein access (pressure of Qa [PQa]
of less than -220 mm Hg), (b) the flow resistance in the venous
line of the system (venous pressure [Pv] of more than 420 mm
Hg), and (c) transmembrane pressure (TMP) of more than 180
mm Hg. In 19 out of 34 animals, the negative pressure for Qa
could be tolerated (group 1). In contrast, in 15 animals, it was
not possible to achieve similarly high flow rates without
exceeding a PQa of -220 mm Hg. This could not be improved
by catheter rinsing, rotation, or tolerable forward/backward
movement of the catheter or exchange of arterial to venous line
and vice versa, and changes in the limb/pelvis positioning did
not improve PQa. In these animals, blood delivery was changed
from the arterial line of the dual-lumen catheter to the Alt Cath
(group 2), whereas blood return remained via the venous line
of the dual-lumen catheter.
Basic methods
Experimental animals
Female crossbred pigs were used (German Landrace × Large
White, n = 34, weighing 40 ± 5 kg [mean ± standard devia-
tion]). The study protocol was approved by the university ani-
mal care committee and the federal authorities for animal
research in Berlin, Germany. The experiments were performed
at the Department of Comparative Medicine and Laboratory
Animal Sciences (certified by ISO [International Organization
for Standardization] 9001). The principles of laboratory animal
care were followed with respect to the guidelines of the Euro-
pean and German societies of laboratory animal sciences.Page 2 of 11
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Anesthesia was administered according to the following intra-
venous anesthesia regimen: Premedication consisted of intra-
muscular injection of azaperon (5 mg/kg Stressnil®; Janssen-
Cilag GmbH, Neuss, Germany), ketamine (10 mg/kg Urso-
tamin®; Serumwerk Bernburg AG, Bernberg, Germany), and
atropine sulfate (0.03 mg/kg Atropin Sulfat®; B. Braun Mel-
sungen AG). Propofol injection enabled tolerance for intuba-
tion (intravenous 5 to 7 mg/kg Propofol 1% MCT®; Fresenius
Kabi AG). Anesthesia was maintained by constant infusion of
thiopentone (14 to 20 mg/kg per hour Trapanal®; ALTANA
Pharma AG, now part of the Nycomed Group, Roskilde, Den-
mark) and fentanyl (3.5 to 6 μg/kg per hour Fentanyl®; Jans-
sen-Cilag GmbH). Guidelines established for the
Figure 1
Assignment of animals to different basic conditions and catheter groups. (a) This schematic diagram shows the steps taken to form a clinically rele-
vant range of hemorheological and hemodynamic conditions. Immature pigs provide a wide range of conditions because of their species-related 
physiological development and growth characteristics. Induction of anesthesia leads to transient lactate acidosis and increased lactate levels in the 
blood for up to several hours. Volume substitutes were chosen to correspond to the most commonly used and most controversial solutions. (b) Dia-
gram of the type of dual-lumen catheter used in this study. ALB, human albumin; CO, cardiac output; COP, colloid osmotic pressure; GEL, gelatin; 
HES, hydroxyethyl starch; NaCl, normal saline; PQa, pressure of access flow; Qb, blood flow; TMP, transmembrane pressure.Page 3 of 11
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were used to assess adequate depth of anesthesia [10]. Ani-
mals were mechanically ventilated (Ventilator 711®; Siemens
AG, Munich, Germany); a volume-controlled mode was used
with continuous positive pressure ventilation and positive end-
expiratory pressure of 5 cm H2O, tidal volume and respiratory
frequency were adjusted to maintain the peak inspiratory pres-
sure below 30 mm Hg, and an inspiratory oxygen fraction of
0.3 and an inspiratory/expiratory ratio of 1:2 were used. The
core body temperature was kept within the normal ranges of
young pigs (38°C to 39°C) by means of a warm touch (Tyco
Healthcare Deutschland GmbH, Neustadt/Donau, Germany).
Instrumentation
We used a combination of the cutdown procedure and
Seldinger's technique to expose blood vessels and introduce
the following catheters: An 8.5-French sheath and a pulmo-
nary artery catheter (CritiCath™, SP5127 S-TIP TD; Becton
Dickinson GmbH, Heidelberg, Germany) were inserted into
the right jugular vein. An axial dual-lumen catheter (11 French,
20 mm long, side holes; Gambro Dialysatoren GmbH) was
introduced into the right femoral vein. The left femoral vein
served for alternative vascular access with an 8.5-French
sheath (Arrow Deutschland GmbH) (Alt Cath) for blood deliv-
ery in case of insufficient Qb via the arterial line of the dual-
lumen catheter. Rinsing of catheters was performed with nor-
mal saline and without any anticoagulation.
Application of colloids and crystalloids
After BS values were measured, pigs received a bolus infusion
of 14 ml/kg of the respective rheologically relevant volume
substitute. CVVH was started, and after a period of 10 to 15
minutes for CVVH equilibration, 'CVVH' baseline values were
measured. Consecutively, a pump-controlled infusion of the
rheologically relevant specific volume substitute was main-
tained (3.9 ml/kg per hour) beside a basic crystalloid infusion
of 5.1 to 5.4 ml/kg per hour, which was suitable for keeping
the animals' mean arterial blood pressure above 50 mm Hg.
Hemodynamics
A Hewlett-Packard monitor (HP 66S; Hewlett-Packard Devel-
opment Company, L.P., Bad Homburg, Germany) was used
for hemodynamic measurements. CVP was continuously
measured and recorded every 30 minutes. CO was measured
by thermodilution using 5-ml bolus injections of normal saline
at room temperature (mean of five consecutive measurements)
every 60 minutes. Arterial pressure was monitored via a femo-
ral artery catheter.
Hemorheological and hemocompatibility parameters
Platelet counts, white blood cell (WBC) counts, hematocrit
(Hct), free hemoglobin (fHb), plasma ALB, total protein (TP),
fibrinogen (Fib), and ALB/TP ratio were determined at the local
Institute for Clinical Chemistry (Charité, Universitätsmedizin
Berlin, Berlin, Germany). Colloid osmotic pressure (COP) was
analyzed from heparinized blood samples by means of a mem-
brane oncometer (BMT 921; Thomae GmbH, Biberach, Ger-
many) (membrane cutoff was 20,000 Da). All parameters were
determined at BS, after CVVH equilibration, and after four and
seven hours of CVVH. Adjustment of heparinization was based
on activated clotting time (ACT), which was determined hourly
(or more frequently if required) by means of a Hemochron
400® (ITC, Edison, NJ, USA). Qb rates, catheter-related pres-
sures, and hemodynamic measurements were also deter-
mined at these time points and served for the following
correlation analyses.
Continuous venovenous hemofiltration
An initial heparin bolus of 100 IU/kg BW was followed by a
continuous heparin infusion to keep ACT values between 200
and 250 seconds (unfractionated heparin: Liquemin®; Hoff-
mann-La Roche AG, Grenzach-Wyhlen, Germany). CVVH and
monitoring of pressures (TMP, Pv, and PQa) were performed
using an AK10® machine and corresponding blood and filtra-
tion lines made from medical-grade polyvinyl chloride, FH 6S
hemofilters (Polyamid S™®, membrane surface of 0.6 m2, inner
diameter of fibers of 215 μm, effective length of 140 mm, and
wall thickness of 50 μm). All CVVH materials used were from
Gambro Dialysatoren GmbH. CVVH was operated in a closed
mode with returning filtrate to the venous bubble trap for five
hours; during the last two hours, post-dilution CVVH was oper-
ated in a standard open mode, which means that the filtrate
was no longer returned for the benefit of crystalloidal volume
substitution, which was initiated instead. At the end of the
experiments, filters were disconnected from the animals and
rinsed with 2 liters of normal saline and a flow rate of 200 ml/
minute. Thereafter, filters were cut open, the overall fiber bun-
dle was visually examined, and the percentage of blocked cap-
illaries was estimated by two independent observations from
two independent investigators. Blocked fibers were red due to
the trapped erythrocytes.
Computed tomography scans
To identify the positioning of the catheter tips and blood vessel
diameters, two additional animals (30 and 50 kg BW) were
scanned after being instrumented with catheter types similar
to those used in the experiments. For computed tomography
(CT), a 16-channel multi-slice device was used (LightSpeed
16®; GE Medical Systems, Milwaukee, IL, USA). The examina-
tion protocol for the imaging of the animals consisted of a non-
contrast-enhanced scan and a supplementary venous phase-
contrast protocol with automatic intravenous injection of 100
ml of non-ionic iodinated contrast media (370 mg/ml iodine).
The scan parameters were standardized (tube current of 120
kV and 140 mA, collimated slice thickness of 16 × 1.25 mm,
total detector width of 20 mm, rotation speed of 0.5 seconds,
and table feed per rotation of 13.75 mm), resulting in a scan
speed of approximately 11 seconds for a 30-cm scan length
in the z-axis. Image analysis was performed using Advantage
Windows 4.2 (GE Medical Systems) and AccuLitePage 4 of 11
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Statistical analysis
Data were analyzed using Sigma STAT 3.1 and Sigma Plot 8.0
for Windows (Systat Software GmbH, Erkrath, Germany).
Because data were not normally distributed, non-parametric
tests were used. Inter-group comparisons were performed
using the Kruskal-Wallis one-way analysis of variance on ranks
followed by pairwise comparison using Dunn's method (that is,
for hemorheological subgroups created by different volume
substitutes). For inter-group comparison of the two study
groups (dual-lumen [group 1] versus Alt Cath [group 2]), the
Mann-Whitney U test was used. Intra-group analyses compar-
ing start and end of CVVH cycle with continuous Qb were per-
formed using the Wilcoxon rank sum test for paired samples.
The Spearman rank order test was used for correlation analy-
ses. Linear regression analysis was performed to determine
the dependence of PQa on hemorheological/hemodynamic
parameters and the dependence of PQa and Pv on Qb rate. A
p value of less than 0.05 was considered statistically
significant.
Results
All subgroups with respective volume substitutes provided
similar values of BW (in kilograms), hemodynamics, and blood
composition tested (data are not shown separated into sub-
groups). Thus, equal conditions were given for all animals in
the two different catheter groups. Regression analysis of BW
(in kilograms) versus CO proved dependency of CO on BW (r
= 0.379; p < 0.001). Changes of CO throughout the time
course of the protocol within each animal ranged from 0.5 to
2 liters/minute and were independent of the subgroup or the
individual BW. Thus, using a range of BW of 35 to 50 kg in
immature domestic pigs and a bolus volume load at the begin-
ning was apt to provide clinically relevant ranges of CO (2.48
to 7.53 liters/minute) to verify the hypothesis that CO may be
a determinant factor in achievable Qa. Blood composition
(that is, low Hct, low COP, and low Fib) showed values of crit-
ically ill patients such as after hemorrhage.
Catheter-related results
As mentioned in the description of the study design, in approx-
imately 44% of the experiments, dual-lumen catheters were
not suitable to allow high Qb rates (that is, of more than 300
ml/minute). In three animals, even an initial Qb rate as low as
75 ml/minute could not be achieved and consequently the use
of the Alt Cath was necessary. Figure 2a displays the maximal
Qb values achieved with the two different catheter types
within CVVH system pressure thresholds. In both groups, Qb
could have been higher if just the thresholds for PQa had been
considered. However, with respect to a limitation for a further
increase in Qb, group 2 (Alt Cath) demonstrated wider dis-
crepancies between TMP thresholds and PQa thresholds than
the dual-lumen group.
Additional box plots (Figure 2b) demonstrate a similar Qb dis-
tribution throughout the time span of the protocol for the two
groups. Although there were fewer difficulties in achieving
high Qb values in animals handled continuously with the dual-
lumen catheter, PQa was significantly lower for group 1 than for
group 2 (Alt Cath) (Figure 2c). Interestingly, as indirectly deter-
mined by monitoring of the resulting Pv levels, no differences
were found for the flow resistance in the venous line of dual-
lumen catheters between the groups (Figure 2d).
There was no statistically significant impact of any particular
volume substitute on the functionality of the catheters (that is,
PQa, Pv, and Qb maximum). Hemorheologically important data
describing the blood composition, such as COP and TP (for
blood viscosity), ALB/TP ratio (for blood cell aggregability), Fib
values (blood cell aggregability, coagulation, and viscosity),
WBC (fluid dynamics, cell adhesion, and clot formation), and
Hct (cell aggregability and viscosity), did not significantly differ
between the two main study groups (therefore, data are not
shown). Likewise, no regression of PQa with any of the afore-
mentioned, hemorheologically relevant, potential trigger
parameters was found, although these parameters were within
critical ranges for hemorheology in critically ill patients. How-
ever, CO and CVP did not differ between the groups or influ-
ence the catheters' functionality (Figure 3a,b). There was no
linear regression for PQa and CO or CVP.
Biocompatibility of catheters
Given that the catheters were not the only artificial devices that
could contribute to adverse side effects in biocompatibility in
the present study, the following results were found. Although
rinsing of catheters was performed with pure saline without
heparinization, no clot formation at the catheter tips was
observed in group 2 (Alt Cath) at the end of the experiment.
However, some Alt Caths had thin blood cell layers on the
inner surface close to the hemostasis valve but no distinct clot
formation in that area. Dual-lumen catheters of group 1 dem-
onstrated more or less pronounced clot formation at the side
holes for blood delivery. The latter indicated side hole-associ-
ated sensitivity for rinsing procedures without anticoagulation.
We found clot formation most often at the tip for blood return,
which is in confirmation with the results for Pv. Blood values
for platelet and WBC counts (Figure 3c,e) did not differ
between the catheter study groups. fHb (Figure 3d) was sig-
nificantly higher in group 2 (Alt Cath), in which additionally a
tendency (not significant) for a higher percentage of blocked
hemofilter hollow fibers was observed (Figure 3f), but fHb
remained at the lower limits of normal ranges and the protocol
did not allow us to discriminate between catheter- and hemo-
filter-related hemolysis.
However, a significant linear regression for Qb and corre-
sponding PQa was found for both catheter types, although the
regression was higher for the small and long lumen in the dual-
lumen catheter (group 1) than for the Alt Cath (group 2)Page 5 of 11
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pressure section of the CVVH system, did not show linear
regression of Qb and flow resistance (Pv) (Figure 4) in either
group.
The CT scans indicate that the catheter tip of the 8.5-French
sheath (Alt Cath) did not reach the vena cava inferior but was
positioned in the common iliac vein (Figures 5 and 6). Thus,
differences in regional CO values had no impact on Qa via the
respective catheter. Furthermore, images of dual-lumen cathe-
ters showed that the tip of the catheter was decentralized and
was located close to the intima of the vein (Figure 5). Because
low CVP or smaller veins with thinner walls could be assumed
to be a reason for this observation, we also investigated the
resulting positioning of the catheter tip in the artery system,
which is the strongest contrast of basic conditions for a cath-
eter positioning. As demonstrated in Figure 6, introduction of
an 11-French, 20 cm-long, dual-lumen catheter into the artery
system via the femoral artery results in an intima-close position
of the dual-lumen catheter tip. Thus, contact of the tip holes to
the blood vessel intima is not a vein-specific feature. Taken
together with the results of blood vessel diameters and vessel
type in which the catheters were positioned, neither vessel
diameter, nor regional CO, nor Qb dynamics could be identi-
fied as a potential trigger for Qa during CVVH in anesthetized,
ventilated pigs.
Discussion
This study was performed to verify reasons for limited Qa via
dual-lumen catheters when placed in central veins (vena cava
via puncture of the femoral vein). Our main results are as fol-
lows: (a) The 8.5-French Alt Cath with tip position in the
Figure 2
Blood flow (Qb) rates and catheter type-related pressure values for access flow (PQa) and blood return (venous pressure [Pv]). Data of all experi-
ments and time points during continuous venovenous hemofiltration within each study group were summarized, and data distribution is visualized 
using box plots. The boxes indicate 25th and 75th percentiles, and the medians are shown by the bars within the box plots. Bars provide minimum/
maximum values, including outliers. Because we focused on alternatives covering all patients and outliers are part of the very nature of critically ill 
patients and in turn the topic of this study, we did not accept data classified as outlier. (a) Highest Qb rates achievable in the respective study 
groups. (b) A summary of all Qb rates used in the respective study groups. In both catheter study groups, comparable blood flow rates were used 
with similar distributions of different Qb rates. (c) PQa values measured in the respective study groups. (d) Pv levels measured in the respective study 
groups.Page 6 of 11
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French dual-lumen catheter with side holes in the caval vein
and achieved flow rates described for 14.5-French catheters
with right atrial tip position [2]. (b) Neither CO, CVP, blood
vessel diameters, vessel type nor differences in hemorheology
based on different types of volume substitutes were proven to
correlate with the levels of negative pressure arising from the
arterial line of the dual-lumen catheter or the Alt Cath. (c) Qb
rate correlated with the flow resistance (PQa) for Qa but did
not correlate with flow resistance for blood return (Pv levels).
Figure 3
Parameters assumed to influence blood flow (Qb) rates achievable via the blood delivery line of catheters. Data of all experiments and time points 
during continuous venovenous hemofiltration within each study group were summarized, and data distribution is visualized using box plot presenta-
tion. The boxes indicate 25th and 75th percentiles, and the medians are shown by the bars within the boxes. Bars provide minimum/maximum val-
ues, including outliers. (a,b) Hemodynamic parameters. Central venous pressure (CVP) (a) and cardiac output (CO) (b), which are assumed to 
determine access flow via the arterial line of dual-lumen catheters. (c-f) Biocompatibility parameters for the two study groups. (c) Plt, platelets. (d) 
fHb, free plasma hemoglobin. (e) WBC, white blood cell counts. (f) Percentage of finally blocked fibers in the hemofilter.Page 7 of 11
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approach often depend on hemodynamics in the critically ill
appears to be quite reasonable, we could not confirm this
assumption in our porcine model based on femoral vein
access with an axial, side-hole, 11-French, dual-lumen
catheter with tip position in the caval vein. In agreement with
the functional intra vitam results of our study, catheter position
was not the main determinant for Qa in the way previously
assumed. Qa was found to be independent of low or high CO
and CVP values as well as of hemorheological differences as
far as could be determined in this study. Because we aimed at
the highest Qb and filtration rates, we had to increase and
reduce flow rates stepwise according to pressure thresholds,
including the use of a filtration pump to generate equal net fil-
tration rates comparably between the study groups. Therefore,
we could not use the hemopermeability index (spontaneous
ultrafiltration rate divided by TMP), which would have been
helpful to indicate membrane fouling/clogging during the time
course of the protocol and in turn could have indirectly indi-
cated differences in hemorheology [11]. The use of long dual-
Figure 4
Linear regression analysis for the dependency of pressure of access flow (PQa) and venous pressure (Pv) on blood flow (Qb)
flow (PQa) and venous pressure (Pv) on blood flow (Qb). All data 
obtained during continuous venovenous hemofiltration within each 
study group were summarized for regression analysis independent of 
the time point or the protocol. For the linear regression analysis of the 
dependency of Pv on Qb, it has to be considered that the venous line 
of the dual-lumen catheter was used for blood return in both catheter 
groups throughout the whole time course of the protocol. However, 
there was an important difference for Pv level development between 
the groups. In the alternative catheter group, access flow (Qa) was per-
formed via a contralateral vein as compared to blood return, whereas in 
the dual-lumen group, only a specific distance between the holes for 
blood return and the holes for blood delivery separated flow dynamics 
at the catheter tip for Qa from blood return.
Figure 5
Computed tomography (CT) scans for identification of catheter tip position (body weight of 50 kg)
position (body weight of 50 kg). All images are derived from a pig that 
was treated with intravenous contrast media. Although the time span 
between application and CT scan allowed contrasting ureters, contrast 
in the vascular system did not pronounce the veins. The upper image 
shows three-dimensional reconstructed volume. Due to rapid renal 
excretion of the contrast media (ureters are contrasted), vessels are not 
visible. Both catheters (dual-lumen and alternative catheter [Alt Cath]) 
enter the vessels at the level of the pelvis. Whereas the tip of the dual-
lumen catheter is positioned in the inferior caval vein, the tip of the Alt 
Cath is positioned in the common iliac vein. The lower images are 
derived from non-contrast-enhanced imaging of the pelvis in the 'abdo-
men window' (window 350, center 50 Hounsfield units). In the area of 
the inferior caval vein (red), the dual-lumen catheter tip was close to the 
inner wall of the vein. Curved reconstruction was performed for the Alt 
Cath. Orange line shows the vessel entry point. Inferior caval veins 
were 11 × 17.6 mm in diameter.Page 8 of 11
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Available online http://ccforum.com/content/11/1/R18lumen catheter aims at positioning the catheter tip in the caval
vein and thereby providing the highest regional CO values,
largest diameter, and highest regional volume state. The best
way to achieve these conditions is to place the catheter tip into
the right atrium, providing blood delivery and return via a sin-
gle-vein approach [2].
The CT scans of instrumented animals show that the catheter
tip position (common iliac vein) of the Alt Cath used in the
present study can be assumed to be insufficient for high Qa.
Nonetheless, the Alt Cath provided higher Qa than the axial,
side-hole, dual-lumen catheter in the caval vein position. The
flow rates achieved were similar to those described for the
right atrial approach with 14.5-French catheters [2]. Again,
one has to consider that in the animals handled with the Alt
Cath, the dual-lumen catheter failed to deliver sufficient Qa.
After we switched to the Alt Cath in these animals, only the
hemofilter or the Pv level limited a further increase in flow rates.
Thus, the Alt Cath provided a favorable performance. Because
high-volume hemofiltration meanwhile becomes of greater
interest for therapy of sepsis and multiple organ failure, our
results may be quite helpful for overcoming low-flow problems
from the side of vascular access in many patients. The use of
alternative principles such as a 'dual-vein approach' could also
reduce the filter clearance limitations due to high Pv levels as
investigated and recently published elsewhere [8,12].
Commonly used catheters for renal replacement therapies,
plasmapheresis, hemoperfusion, or extracorporeal membrane
oxygenation are introduced via Seldinger's technique to
reduce maneuver-related trauma. Therefore, these catheters
require mechanically stable, cone-forming catheter tips to
facilitate the percutaneous insertion through the connective
tissue without any deformation. The tapered catheter tip is
another limiting factor for flow dynamics/resistance [13].
Although side holes may provide higher Qa rates in the case
of right atrial position, they also increase the risk of clot forma-
tion and infections. Placed in a central vein position, side holes
may lead to intima attachment, reducing Qa and increasing the
risk of thrombus formation. Thus, by the introduction of a mod-
ified Seldinger's technique whereby the function of a tapered
tip is transferred to an introducer, catheters with a wide circu-
lar tip hole could be beneficial with respect to blood delivery.
Methods
The use of immature pigs provides the unfavorable hemorheo-
logical conditions often encountered in critically ill patients
due to multiple etiologies [14-16]. In pigs, however, unfavora-
ble hemorheological conditions occur due to the pigs' physiol-
ogy and not in response to pathophysiological conditions.
Furthermore, the CO values in pigs were within the ranges rel-
evant in critically ill patients.
However, experimental conditions are not comparable to the
clinical situation. We had to operate CVVH with a return of the
Figure 6
Computed tomography scans for identification of catheter tip position (b dy w ight of 30 kg)
(body weight of 30 kg). Diameters of blood vessels are 10.88 × 9.33 
mm (aorta), 6.6 × 9.3 mm (common iliac vein), and 13.6 × 8.86 mm 
(inferior caval vein at the level of the dual-lumen catheter tip). The upper 
image shows a three-dimensional reconstruction of the pig from a 
mixed arteriovenous, contrast-enhanced scan. With respect to all three 
catheters, the tip was close to the vessel wall. Contrast-enhanced 
image of the pelvis in the bone window (window 2,500, center 500 
Hounsfield units [HU]) to visualize the catheter in contrast-filled aorta. 
In this pig, the dual-lumen catheter was inserted into the arterial system 
in order to determine whether the tip position of the dual-lumen cathe-
ter at the intima depends on flow dynamics and vessel wall characteris-
tics. The lower image shows an enhanced image of the pelvis in the 
bone window (window 2500, center 500 HU) to visualize the catheters 
in contrast-filled vessels. In this animal, curved reconstruction was per-
formed for the alternative catheter (Alt. Cath.). Orange line shows the 
vessel entry point. The catheters are visualized lying in the right and left 
iliac arteries and the right iliac vein. Interestingly, the dual-lumen cathe-
ter again was visualized at the lateral wall of the blood vessel.Page 9 of 11
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Critical Care    Vol 11 No 1    Unger et al.filtrate to the animal for several hours in order to avoid a severe
washout of healthy animals. As a result, washout was
restricted to the last two hours in the open post-dilution mode.
We integrated a small hemofilter into the setting because the
hemocompatibility effects of all CVVH components mutually
affect each other and thus have to be considered for clinical
relevance of results. Furthermore, this setting allowed us eval-
uate whether a small hemofilter (0.6 m2 effective membrane
surface) or the respective catheter type was the limiting
aspect for a potential increase of CVVH-related clearance
based on post-dilution mode. We chose an axial dual-lumen
catheter with side holes for blood delivery and return because
this type was declared by two companies to be the type most
often sold (and thus used) for CVVH. Because we chose a
small hemofilter for small overall surface of the extracorporeal
system and young pigs, we also used a smaller size (11
French). In addition to the failure of the dual-lumen catheter
concerning Qa, the Pv was the major limit for filtration perform-
ance by increasing the TMP above a tolerable threshold, which
is in confirmation with our former in vitro study [8]. Thus, also
from a retrospective point of view, running a complete CVVH
appears to be the best choice for our study design. Because
there were no clear signs of hemo-incompatibility, the 8.5-
French sheath used in this setting was also adequate for pro-
viding sufficient blood delivery via a femoral access. Nonethe-
less, with respect to appropriate catheter engineering, there
will be better catheter alternatives for clinical approach of the
'dual-vein principle' whenever right internal jugular vein access
is not possible.
One limitation of this study is that all analyses were based on
the flow rate value set by the pump. However, given that a
reduction of Qb in the case of very low, negative pressures for
Qa was already demonstrated by others [1], one could
assume that the Qb rates in the dual-lumen group in particular
often did not reach flow rates set by the pump. Therefore, the
tendency for superiority in Qa for the Alt Cath group would
probably become highly significant if data analysis could have
been based on real Qb measurements. Another limitation is
the lack of randomized allocation of animals to the catheter
groups. On the other hand, our setting provided an intra-indi-
vidual control between the catheter types. This 'crossover' sit-
uation is the only setting possible for proving that switching to
an alternative vascular access may solve low-flow problems
based on established approaches in the respective animal or
patient.
Conclusion
In this study on CVVH in healthy pigs, we found that blood
delivery rates from the caval vein via a femoral vein access and
thus possibly filter clearance were not correlated with hemo-
dynamics and hemorheology but depended highly on the flow
resistance given by the arterial line of the femoral vein catheter.
When a percutaneous modified Seldinger's technique with an
introducer/sheath combination was used, even a more distal
venous catheter position provided flow rates exceeding those
described for 14.5-French dual-lumen catheters with right
atrial tip position in humans. Because the experimental model
was set to accelerate unfavorable effects in biocompatibility, a
direct comparison to clinical circumstances is not given. How-
ever, if the right internal jugular vein/atrium approach is ham-
pered in the critically ill patient and the usual maneuvers to
increase filtration performance (such as pre-dilution, heparin
priming, and anticoagulatory catheter locks) do not work, a
'dual-vein approach' could be the last option for a high clear-
ance in CVVH without further upscaling of hemofilters. Thus, it
would be of interest to obtain clinical data to validate these
first experimental results.
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Key messages
• Blood delivery rates from the caval vein via an axial, 
side-hole, dual-lumen catheter did not correlate with 
hemodynamics, size of blood vessels, or hemorheologi-
cal impact of colloids.
• Even with low CO, a short 8.5-French catheter with a 
central tip hole provided Qb from the common iliac vein 
comparable to long 14.5-French dual-lumen catheters 
with right atrial tip position.
• It seems worthwhile to clinically re-investigate the prin-
ciple of 'dual-vein approach' with large vein access for 
blood delivery and probably peripheral vein access for 
blood return in order to provide alternatives when estab-
lished approaches are failing.Page 10 of 11
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